论文部分内容阅读
目的:观察滋阴熄风活血汤结合西药治疗帕金森病术后患者的疗效。方法:将60例患者随机分为2组各30例,2组均采用基础治疗,治疗组予滋阴熄风活血汤加美多芭片治疗,对照组予美多芭片治疗,2组疗程均为3月。评定2组的临床疗效,评价治疗前后的中医老年颤证功能障碍评分、帕金森病功能评定量表(UPDRS)评分。结果:2组临床疗效比较,差异无统计学意义(P>0.05)。治疗后,2组中医老年颤证功能障碍评分均较治疗前降低,差异均有统计学意义(P<0.01);2组评分比较,差异无统计学意义(P>0.05)。治疗组UPDRS评分与治疗前、对照组治疗后降低,差异均有统计学意义(P<0.01,P<0.05),对照组UPDRS评分较治疗前升高(P<0.05),2组UPDRS评分比较,差异有统计学意义(P<0.05)。治疗期间治疗组未见不良反应。结论:滋阴熄风活血汤加美多芭片治疗帕金森病术后患者可减轻临床症状,改善和提高生活质量。
Objective: To observe the efficacy of Ziyin Xifenghuoxue Decoction combined with western medicine in the treatment of patients with Parkinson’s disease. Methods: Sixty patients were randomly divided into two groups of 30 cases. The two groups were treated with basic therapy. The treatment group was treated with Ziyin Xifenghuoxue Tonga Meaduo Tablet, while the control group was treated with Meiduodan tablets. For March. The clinical efficacy of the two groups was evaluated, and the scores of dysfunction of TCM syndromes in elderly patients and the Parkinson’s Disease Functional Rating Scale (UPDRS) were evaluated before and after treatment. Results: There was no significant difference in clinical efficacy between the two groups (P> 0.05). After treatment, the score of dysfunction of TCM syndromes in elderly patients in both groups was lower than that before treatment (P <0.01). There was no significant difference between the two groups (P> 0.05). The UPDRS score of the treatment group was significantly lower than that of the control group before and after treatment (P <0.01, P <0.05), while the UPDRS score of the control group was significantly higher than that before treatment (P <0.05) , The difference was statistically significant (P <0.05). The treatment group during treatment no adverse reactions. Conclusion: Ziyin Xifenghuoxue Tonga Meaduo tablets in patients with Parkinson’s disease can reduce the clinical symptoms, improve and improve the quality of life.